Evidence map›Paper›PMID 25595798›Full record

ArticleThe EMBO journal2015

Transport through recycling endosomes requires EHD1 recruitment by a phosphatidylserine translocase.

Shoken Lee, Yasunori Uchida, Jiao Wang, Tatsuyuki Matsudaira, Takatoshi Nakagawa, Takuma Kishimoto, Kojiro Mukai, Takehiko Inaba, Toshihide Kobayashi, Robert S Molday and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 136 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Shoken LeeDepartment of Health Chemistry, Graduate School of Pharmaceutical Sciences University of Tokyo, Tokyo, Japan.
Yasunori UchidaDepartment of Health Chemistry, Graduate School of Pharmaceutical Sciences University of Tokyo, Tokyo, Japan.
Jiao WangDepartments of Biochemistry and Molecular Biology and Ophthalmology and Visual Sciences, Centre for Macular Research University of British Columbia, Vancouver, BC, Canada.
Tatsuyuki MatsudairaDepartment of Health Chemistry, Graduate School of Pharmaceutical Sciences University of Tokyo, Tokyo, Japan.
Takatoshi NakagawaDepartment of Pharmacology, Osaka Medical College, Takatsuki-city Osaka, Japan.
Takuma KishimotoLipid Biology Laboratory, RIKEN, Wako-shi Saitama, Japan.
Kojiro MukaiDepartment of Health Chemistry, Graduate School of Pharmaceutical Sciences University of Tokyo, Tokyo, Japan Lipid Biology Laboratory, RIKEN, Wako-shi Saitama, Japan.
Takehiko InabaLipid Biology Laboratory, RIKEN, Wako-shi Saitama, Japan.
Toshihide KobayashiLipid Biology Laboratory, RIKEN, Wako-shi Saitama, Japan.
Robert S MoldayDepartments of Biochemistry and Molecular Biology and Ophthalmology and Visual Sciences, Centre for Macular Research University of British Columbia, Vancouver, BC, Canada.
Tomohiko TaguchiDepartment of Health Chemistry, Graduate School of Pharmaceutical Sciences University of Tokyo, Tokyo, Japan Pathological Cell Biology Laboratory, Graduate School of Pharmaceutical Sciences University of Tokyo, Tokyo, Japan tom_taguchi@mol.f.u-tokyo.ac.jp harai@mol.f.u-tokyo.ac.jp.
Hiroyuki AraiDepartment of Health Chemistry, Graduate School of Pharmaceutical Sciences University of Tokyo, Tokyo, Japan Pathological Cell Biology Laboratory, Graduate School of Pharmaceutical Sciences University of Tokyo, Tokyo, Japan tom_taguchi@mol.f.u-tokyo.ac.jp harai@mol.f.u-tokyo.ac.jp.
University of Tokyo Health Sciences · JPRIKEN · JPUniversity of British Columbia · CAOsaka Medical and Pharmaceutical University · JP

Funding

STRUCTURE/FUNCTION OF ROS PLASMA MEMBRANE PROTEINSR01EY002422 · NEI · UNIVERSITY OF BRITISH COLUMBIA · PI MOLDAY, ROBERT S · 1985 to 2017
$3.5M
Canadian Institutes of Health Research MOP-106667NEI NIH HHS EY002422NEI NIH HHS R01 EY002422
6 · The paper itself

Abstract

P4-ATPases translocate aminophospholipids, such as phosphatidylserine (PS), to the cytosolic leaflet of membranes. PS is highly enriched in recycling endosomes (REs) and is essential for endosomal membrane traffic. Here, we show that PS flipping by an RE-localized P4-ATPase is required for the recruitment of the membrane fission protein EHD1. Depletion of ATP8A1 impaired the asymmetric transbilayer distribution of PS in REs, dissociated EHD1 from REs, and generated aberrant endosomal tubules that appear resistant to fission. EHD1 did not show membrane localization in cells defective in PS synthesis. ATP8A2, a tissue-specific ATP8A1 paralogue, is associated with a neurodegenerative disease (CAMRQ). ATP8A2, but not the disease-causative ATP8A2 mutant, rescued the endosomal defects in ATP8A1-depleted cells. Primary neurons from Atp8a2-/- mice showed a reduced level of transferrin receptors at the cell surface compared to Atp8a2+/+ mice. These findings demonstrate the role of P4-ATPase in membrane fission and give insight into the molecular basis of CAMRQ.

Indexed as

Models, BiologicalAdenosine TriphosphatasesAnalysis of VarianceAnimalsBacterial ProteinsBiological TransportBlotting, WesternChlorocebus aethiopsCOS CellsDNA, ComplementaryDNA PrimersEndosomesHeLa CellsHumansImmunohistochemistryMiceAdenosine TriphosphatasesATP8A1 protein, humanATP8a2 protein, mouseBacterial ProteinsDNA, ComplementaryDNA PrimersEHD1 protein, humanPhosphatidylserinesPhospholipid Transfer Proteinsstreptolysin OStreptolysinsVesicular Transport ProteinsATP8A1EHD1phosphatidylserinephospholipid flippaserecycling endosomes

Identifiers

PMID25595798
PMCPMC4365035
OpenAlexW2122284898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.